Search | Page 16 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

    ... risk myelodysplastic syndrome (MDS) that is relapsed/ refractory to erythropoiesis-stimulating agent (ESA) treatment. ...

    Clinical Trial last updated 04/20/2016 - 3:39pm.

  2. Myelodysplastic Syndromes and autoimmune disorders: Cause or consequence?

    ... neutrophilic dermatosis. Vasculitis is most common in refractory anemia with excess blasts (RAEB) and chronic ...

    Research Review last updated 05/02/2016 - 9:18am.

  3. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... high risk for relapse, or second or third CR, or relapse/ refractory less than or equal to 10% blasts in bone marrow , ... component is in CR. Hodgkin's lymphoma that is primary refractory or relapsed not suitable for other therapy and in PR or CR or small ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.

  4. Phoenix Ho, MD

    ... (MDS), and childhood leukemia, including relapsed and refractory disease Clinical Interests: Inherited Bone Marrow ...

    Bio last updated 03/11/2016 - 1:41pm.

  5. Amer Zeidan, M.D.

    ... area is the development of novel therapies for MDS and refractory myeloid malignancies with a focus on immune therapy including ...

    Bio last updated 03/11/2016 - 1:41pm.

  6. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... Leukemia (untreated, in remission or with refractory or relapsed disease) Donors will be either human ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.

  7. Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

    ... 2nd or greater complete remission, partial remission, or refractory relapse Chronic lymphocytic leukemia (CLL), Rai Stage 2-4, ...

    Clinical Trial last updated 05/02/2016 - 2:07pm.

  8. Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    ... Lymphoblastic Leukemia (ALL): induction failure, primary refractory to treatment (do not achieve complete remission after first ... induction failure, second or third complete remission, refractory disease, or relapse (including relapse post autologous hematopoietic ...

    Clinical Trial last updated 06/06/2016 - 12:58pm.

  9. Nonmyeloablative Allogeneic Transplant (Mini-allo)

    ... Incomplete response to induction Second CR Sensitive or refractory relapse Indolent Histology Second or greater relapse ...

    Clinical Trial last updated 04/28/2016 - 2:13pm.

  10. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... or progression of disease on hypomethylating agents, 4) refractory anemia with excess of blasts , 5) transformation ... Lymphoblastic Leukemia (ALL): Induction failure, primary refractory to treatment (do not achieve complete remission after first course ...

    Clinical Trial last updated 06/06/2016 - 10:28am.